Macquarie Group Ltd

SEC CIK: 0001418333
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overview All 13F holders of RXRX Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2022

Holdings of RXRX by Macquarie Group Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−4,927−100.0%	Sold out	Holders
Q3 2022	4,927	$52.0K	<0.1%	00.0%	Unchanged	Holders
Q2 2022	4,927	$40.0K	<0.1%	00.0%	Unchanged	Holders
Q1 2022	4,927	$35.0K	<0.1%	+4,927	New	Holders